Skip to main content
. Author manuscript; available in PMC: 2009 Jun 8.
Published in final edited form as: Mult Scler. 2008 Jun 5;14(6):770–778. doi: 10.1177/1352458507088104

Figure 3.

Figure 3

Number of new contrast enhancing lesions per scan over 6 months for n = 208 patients from 11 clinical trials versus 6-month relapse rate (concurrent validity) and versus 12-month relapse rate (predictive validity).